Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Dec;87(24):9794-7.
doi: 10.1073/pnas.87.24.9794.

Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B

E Ciccone  1 , M Colonna, O Viale, D Pende, C Di Donato, D Reinharz, A Amoroso, M Jeannet, J Guardiola, A Moretta, et al.
Affiliations

Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B

E Ciccone et al. Proc Natl Acad Sci U S A. 1990 Dec.

Erratum in

  • Proc Natl Acad Sci U S A 1991 Jun 15;88(12):5477

Abstract

The specificity recognized on normal allogeneic cells by a given alloreactive (1-anti-A) natural killer clone is controlled by a gene locus termed EC1. Because the EC1 locus was previously shown to be located on chromosome 6, families characterized by a recombinant major histocompatibility complex haplotype were analyzed to map this locus more precisely. The breakpoint of recombination was studied by standard HLA typing, complement typing, and restriction fragment length polymorphism analysis of a series of genes located between the complement cluster genes and HLA-B within the major histocompatibility complex region. Three of 10 families analyzed were informative. From the data obtained, the EC1 locus maps between BF and HLA-B and presumably is one of the normal genes recently described in this region.

PubMed Disclaimer

References

    1. J Exp Med. 1971 Dec 1;134(6):1513-28 - PubMed
    1. Nature. 1964 Dec 5;204:998-1000 - PubMed
    1. J Exp Med. 1972 Jan;135(1):68-80 - PubMed
    1. Clin Immunol Immunopathol. 1975 Jan;3(3):324-33 - PubMed
    1. J Exp Med. 1983 Aug 1;158(2):571-85 - PubMed

Publication types

MeSH terms